Table 1.
Clinicopathological data of analyzed cases.
| Number of cases | % | ||
|---|---|---|---|
| Age | <40 | 12 | 10 |
| ≥40 | 108 | 90 | |
|
| |||
| Tumor size | T0-T1 | 24 | 20 |
| T2 | 24 | 20 | |
| T3 | 24 | 20 | |
| T4 | 48 | 40 | |
|
| |||
| Lymph node | N0 | 8 | 6.7 |
| N1 | 48 | 40 | |
| N2 | 14 | 11.7 | |
| N3 | 46 | 38.3 | |
| Unknown (X) | 4 | 3.3 | |
|
| |||
| Metastasis | Yes | 24 | 20 |
| No | 96 | 80 | |
|
| |||
| Tumor grade | G1 | 2 | 1.7 |
| G2 | 86 | 71.7 | |
| G3 | 12 | 10 | |
| Unknown (X) | 20 | 16.6 | |
|
| |||
| Estrogen receptor (ER) | Positive | 52 | 43.3 |
| Negative | 48 | 40 | |
| Unknown (X) | 20 | 16.7 | |
|
| |||
| Progesterone receptor (PR) | Positive | 40 | 33.3 |
| Negative | 60 | 50 | |
| Unknown (X) | 20 | 16.7 | |
|
| |||
| HER2 | Positive | 14 | 11.7 |
| Negative | 48 | 40 | |
| Unknown (X) | 58 | 48.3 | |